averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXM1 | hg19_v2_chr12_-_2986107_2986258 | -0.27 | 5.8e-05 | Click! |
TBL1XR1 | hg19_v2_chr3_-_176914238_176914277 | -0.23 | 6.4e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91574142 | 70.20 |
ENST00000547937.1
|
DCN
|
decorin |
chr12_-_91572278 | 33.12 |
ENST00000425043.1
ENST00000420120.2 ENST00000441303.2 ENST00000456569.2 |
DCN
|
decorin |
chr18_+_74240610 | 32.61 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
chr12_-_10022735 | 31.64 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr12_-_91573132 | 31.40 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr16_-_30032610 | 30.61 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr3_+_189507460 | 28.70 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
chr12_-_91576429 | 27.41 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr12_-_91576561 | 27.10 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
chr11_+_5710919 | 25.85 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr12_-_91573249 | 24.82 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr4_+_175204818 | 24.56 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
chr22_-_27620603 | 24.14 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
chr12_-_91539918 | 23.79 |
ENST00000548218.1
|
DCN
|
decorin |
chr6_+_33048222 | 23.57 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr12_-_91546926 | 23.51 |
ENST00000550758.1
|
DCN
|
decorin |
chr12_+_66218212 | 22.40 |
ENST00000393578.3
ENST00000425208.2 ENST00000536545.1 ENST00000354636.3 |
HMGA2
|
high mobility group AT-hook 2 |
chr19_+_52901094 | 21.65 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
chr12_+_8995832 | 20.92 |
ENST00000541459.1
|
A2ML1
|
alpha-2-macroglobulin-like 1 |
chr6_+_32605195 | 20.61 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr12_-_15038779 | 20.12 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr11_+_114168085 | 19.08 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr2_-_89459813 | 18.64 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr1_-_20306909 | 17.95 |
ENST00000375111.3
ENST00000400520.3 |
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid) |
chr6_+_33043703 | 17.77 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr11_-_5255696 | 17.68 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
chr3_+_29322437 | 17.50 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr1_-_169680745 | 17.03 |
ENST00000236147.4
|
SELL
|
selectin L |
chr17_+_41857793 | 16.53 |
ENST00000449302.3
|
C17orf105
|
chromosome 17 open reading frame 105 |
chr5_+_40909354 | 16.49 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr3_-_112127981 | 16.40 |
ENST00000486726.2
|
RP11-231E6.1
|
RP11-231E6.1 |
chr16_+_58283814 | 16.26 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
chr22_+_23264766 | 16.09 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr12_+_69742121 | 15.87 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr19_-_6690723 | 15.79 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr18_-_21017817 | 15.77 |
ENST00000542162.1
ENST00000383233.3 ENST00000582336.1 ENST00000450466.2 ENST00000578520.1 ENST00000399707.1 |
TMEM241
|
transmembrane protein 241 |
chr1_-_161277210 | 15.64 |
ENST00000491222.2
|
MPZ
|
myelin protein zero |
chr19_+_49838653 | 15.59 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr13_-_46756351 | 15.08 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr22_+_23241661 | 14.87 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr3_+_29323043 | 14.84 |
ENST00000452462.1
ENST00000456853.1 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr7_+_73623717 | 14.68 |
ENST00000344995.5
ENST00000460943.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chrX_-_55057403 | 14.66 |
ENST00000396198.3
ENST00000335854.4 ENST00000455688.1 ENST00000330807.5 |
ALAS2
|
aminolevulinate, delta-, synthase 2 |
chr13_-_30881621 | 14.65 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr19_+_19976714 | 14.65 |
ENST00000589717.1
ENST00000355650.4 |
ZNF253
|
zinc finger protein 253 |
chr17_-_41465674 | 14.63 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
chr6_+_32709119 | 14.61 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr2_-_90538397 | 14.54 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr1_+_145439306 | 14.53 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
chr17_-_29641084 | 14.47 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr19_+_41509851 | 14.47 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
chr19_-_37701386 | 14.31 |
ENST00000527838.1
ENST00000591492.1 ENST00000532828.2 |
ZNF585B
|
zinc finger protein 585B |
chr7_+_80275621 | 14.31 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr2_+_87565634 | 14.30 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr9_+_75766652 | 13.84 |
ENST00000257497.6
|
ANXA1
|
annexin A1 |
chr5_-_42812143 | 13.77 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr1_+_153330322 | 13.48 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr22_+_23237555 | 13.39 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr2_-_238322800 | 13.29 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
chr8_-_90769422 | 13.25 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
chr12_-_8815404 | 13.24 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
chr1_+_89829610 | 13.14 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
chr19_-_36399149 | 13.12 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr2_-_238322770 | 13.11 |
ENST00000472056.1
|
COL6A3
|
collagen, type VI, alpha 3 |
chr19_+_42381173 | 13.08 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr6_+_111580508 | 13.08 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
chr18_+_71815743 | 13.07 |
ENST00000169551.6
ENST00000580087.1 |
TIMM21
|
translocase of inner mitochondrial membrane 21 homolog (yeast) |
chr11_+_114128522 | 13.04 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr3_-_138763734 | 13.03 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
chr3_+_29322803 | 13.02 |
ENST00000396583.3
ENST00000383767.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chrX_-_70329118 | 13.02 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
chr12_-_15104040 | 12.96 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chrX_-_107018969 | 12.88 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr1_+_198608146 | 12.84 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr1_+_158815588 | 12.70 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr9_+_74526384 | 12.62 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr11_-_5248294 | 12.55 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr6_+_56954867 | 12.49 |
ENST00000370708.4
ENST00000370702.1 |
ZNF451
|
zinc finger protein 451 |
chr3_+_29322933 | 12.39 |
ENST00000273139.9
ENST00000383766.2 |
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr2_-_238323007 | 12.35 |
ENST00000295550.4
|
COL6A3
|
collagen, type VI, alpha 3 |
chr2_+_113033164 | 12.27 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
chr4_-_46911223 | 12.27 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr17_-_34313685 | 12.24 |
ENST00000435911.2
ENST00000586216.1 ENST00000394509.4 |
CCL14
|
chemokine (C-C motif) ligand 14 |
chr22_+_23247030 | 12.24 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr7_+_80275953 | 12.18 |
ENST00000538969.1
ENST00000544133.1 ENST00000433696.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr13_-_38172863 | 12.11 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr1_-_12677714 | 12.06 |
ENST00000376223.2
|
DHRS3
|
dehydrogenase/reductase (SDR family) member 3 |
chr15_-_47426320 | 12.05 |
ENST00000557832.1
|
FKSG62
|
FKSG62 |
chr11_+_82612740 | 12.04 |
ENST00000524921.1
ENST00000528759.1 ENST00000525361.1 ENST00000430323.2 ENST00000533655.1 ENST00000532764.1 ENST00000532589.1 ENST00000525388.1 |
C11orf82
|
chromosome 11 open reading frame 82 |
chr12_+_75874580 | 11.93 |
ENST00000456650.3
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr11_-_5255861 | 11.92 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
chr8_-_27941380 | 11.90 |
ENST00000413272.2
ENST00000341513.6 |
NUGGC
|
nuclear GTPase, germinal center associated |
chr6_-_32920794 | 11.89 |
ENST00000395305.3
ENST00000395303.3 ENST00000374843.4 ENST00000429234.1 |
HLA-DMA
XXbac-BPG181M17.5
|
major histocompatibility complex, class II, DM alpha Uncharacterized protein |
chr19_-_10333842 | 11.88 |
ENST00000317726.4
|
CTD-2369P2.2
|
CTD-2369P2.2 |
chr11_-_85565906 | 11.81 |
ENST00000544076.1
|
AP000974.1
|
CDNA FLJ26432 fis, clone KDN01418; Uncharacterized protein |
chr2_+_90211643 | 11.78 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr2_+_189839046 | 11.74 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr3_-_46506358 | 11.74 |
ENST00000417439.1
ENST00000431944.1 |
LTF
|
lactotransferrin |
chr16_-_75498553 | 11.69 |
ENST00000569276.1
ENST00000357613.4 ENST00000561878.1 ENST00000566980.1 ENST00000567194.1 |
TMEM170A
RP11-77K12.1
|
transmembrane protein 170A Uncharacterized protein |
chr12_-_11422630 | 11.69 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
chr14_+_75745477 | 11.66 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr21_+_27011584 | 11.66 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr5_-_42811986 | 11.64 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr12_-_8815299 | 11.59 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
chr12_-_91573316 | 11.59 |
ENST00000393155.1
|
DCN
|
decorin |
chr3_-_46506563 | 11.53 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
chr1_+_202830876 | 11.51 |
ENST00000456105.2
|
RP11-480I12.7
|
RP11-480I12.7 |
chr2_+_90273679 | 11.51 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr12_-_9268707 | 11.50 |
ENST00000318602.7
|
A2M
|
alpha-2-macroglobulin |
chr12_-_91576750 | 11.48 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
chr22_-_17680472 | 11.43 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr1_+_117297007 | 11.40 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr14_-_106967788 | 11.40 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr7_+_79998864 | 11.39 |
ENST00000435819.1
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr7_+_20686946 | 11.33 |
ENST00000443026.2
ENST00000406935.1 |
ABCB5
|
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr4_-_71532339 | 11.12 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr2_-_99224915 | 11.07 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr1_+_161185032 | 11.04 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chrX_-_103401649 | 11.00 |
ENST00000357421.4
|
SLC25A53
|
solute carrier family 25, member 53 |
chrX_+_56259316 | 10.98 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr1_+_169337172 | 10.81 |
ENST00000367807.3
ENST00000367808.3 ENST00000329281.2 ENST00000420531.1 |
BLZF1
|
basic leucine zipper nuclear factor 1 |
chr12_-_10007448 | 10.76 |
ENST00000538152.1
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr6_+_32605134 | 10.73 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr7_+_111846741 | 10.70 |
ENST00000421043.1
ENST00000425229.1 ENST00000450657.1 |
ZNF277
|
zinc finger protein 277 |
chr2_+_127413677 | 10.70 |
ENST00000356887.7
|
GYPC
|
glycophorin C (Gerbich blood group) |
chr17_+_38083977 | 10.69 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr11_+_114166536 | 10.64 |
ENST00000299964.3
|
NNMT
|
nicotinamide N-methyltransferase |
chr16_+_55512742 | 10.63 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr4_+_156587979 | 10.61 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr7_+_26438187 | 10.58 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
chr4_-_46911248 | 10.58 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
chr6_+_6588902 | 10.52 |
ENST00000230568.4
|
LY86
|
lymphocyte antigen 86 |
chr16_-_5115913 | 10.51 |
ENST00000474471.3
|
C16orf89
|
chromosome 16 open reading frame 89 |
chr3_-_155461515 | 10.45 |
ENST00000399242.2
|
AC104472.1
|
CDNA FLJ26134 fis, clone TMS03713; Uncharacterized protein |
chr12_-_8218997 | 10.42 |
ENST00000307637.4
|
C3AR1
|
complement component 3a receptor 1 |
chr19_+_42381337 | 10.42 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr2_+_89975669 | 10.40 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr16_+_30483962 | 10.35 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_+_80275752 | 10.33 |
ENST00000419819.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr2_-_89278535 | 10.27 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr6_-_27858570 | 10.26 |
ENST00000359303.2
|
HIST1H3J
|
histone cluster 1, H3j |
chr13_+_31309645 | 10.26 |
ENST00000380490.3
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein |
chr19_-_11669960 | 10.25 |
ENST00000589171.1
ENST00000590700.1 ENST00000586683.1 ENST00000593077.1 ENST00000252445.3 |
ELOF1
|
elongation factor 1 homolog (S. cerevisiae) |
chr17_-_66951474 | 10.23 |
ENST00000269080.2
|
ABCA8
|
ATP-binding cassette, sub-family A (ABC1), member 8 |
chr6_-_33048483 | 10.19 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr5_+_82767583 | 10.18 |
ENST00000512590.2
ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN
|
versican |
chr1_-_153113927 | 10.11 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
chr4_-_74847800 | 10.11 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
chr2_-_89442621 | 10.10 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr2_+_17935119 | 10.04 |
ENST00000317402.7
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr6_+_31583761 | 10.04 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chr10_+_70847852 | 10.03 |
ENST00000242465.3
|
SRGN
|
serglycin |
chr6_+_31582961 | 10.01 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr19_-_54784937 | 9.99 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr4_+_76439665 | 9.97 |
ENST00000508105.1
ENST00000311638.3 ENST00000380837.3 ENST00000507556.1 ENST00000504190.1 ENST00000507885.1 ENST00000502620.1 ENST00000514480.1 |
THAP6
|
THAP domain containing 6 |
chr6_+_29691056 | 9.92 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
chr19_-_51531272 | 9.91 |
ENST00000319720.7
|
KLK11
|
kallikrein-related peptidase 11 |
chr4_-_84035868 | 9.88 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr10_-_28571015 | 9.85 |
ENST00000375719.3
ENST00000375732.1 |
MPP7
|
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
chr9_-_99417562 | 9.83 |
ENST00000375234.3
ENST00000446045.1 |
AAED1
|
AhpC/TSA antioxidant enzyme domain containing 1 |
chr20_+_814377 | 9.72 |
ENST00000304189.2
ENST00000381939.1 |
FAM110A
|
family with sequence similarity 110, member A |
chr10_+_17272608 | 9.72 |
ENST00000421459.2
|
VIM
|
vimentin |
chr11_+_114168773 | 9.70 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
chr2_+_90060377 | 9.69 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr5_-_140013275 | 9.68 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr19_+_9296279 | 9.68 |
ENST00000344248.2
|
OR7D2
|
olfactory receptor, family 7, subfamily D, member 2 |
chr2_+_90108504 | 9.67 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr13_-_44453826 | 9.63 |
ENST00000444614.3
|
CCDC122
|
coiled-coil domain containing 122 |
chr14_-_81687197 | 9.57 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr7_-_76829125 | 9.57 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr2_-_11272234 | 9.55 |
ENST00000590207.1
ENST00000417697.2 ENST00000396164.1 ENST00000536743.1 ENST00000544306.1 |
AC062028.1
|
AC062028.1 |
chr1_+_158801095 | 9.51 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr3_+_101546827 | 9.44 |
ENST00000461724.1
ENST00000483180.1 ENST00000394054.2 |
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr17_-_40021656 | 9.42 |
ENST00000319121.3
|
KLHL11
|
kelch-like family member 11 |
chr1_+_151043070 | 9.39 |
ENST00000368918.3
ENST00000368917.1 |
GABPB2
|
GA binding protein transcription factor, beta subunit 2 |
chr4_+_156588115 | 9.38 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr6_+_150920999 | 9.37 |
ENST00000367328.1
ENST00000367326.1 |
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
chr4_+_156588249 | 9.34 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr8_-_82395461 | 9.27 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
chr19_+_859425 | 9.23 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr18_+_39766626 | 9.22 |
ENST00000593234.1
ENST00000585627.1 ENST00000591199.1 ENST00000586990.1 ENST00000593051.1 ENST00000593316.1 ENST00000591381.1 ENST00000585639.1 ENST00000589068.1 |
LINC00907
|
long intergenic non-protein coding RNA 907 |
chr6_+_42018251 | 9.19 |
ENST00000372978.3
ENST00000494547.1 ENST00000456846.2 ENST00000372982.4 ENST00000472818.1 ENST00000372977.3 |
TAF8
|
TAF8 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 43kDa |
chr1_+_196788887 | 9.14 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
chr12_-_12491608 | 9.13 |
ENST00000545735.1
|
MANSC1
|
MANSC domain containing 1 |
chr12_+_124155652 | 9.09 |
ENST00000426174.2
ENST00000303372.5 |
TCTN2
|
tectonic family member 2 |
chr14_+_95078714 | 9.08 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr22_+_23243156 | 9.03 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr11_-_59633951 | 9.02 |
ENST00000257264.3
|
TCN1
|
transcobalamin I (vitamin B12 binding protein, R binder family) |
chr3_-_155524049 | 8.84 |
ENST00000534941.1
ENST00000340171.2 |
C3orf33
|
chromosome 3 open reading frame 33 |
chr19_+_51645556 | 8.81 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
chr20_-_35580240 | 8.74 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr5_+_118690466 | 8.74 |
ENST00000503646.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr11_+_92577506 | 8.72 |
ENST00000533797.1
|
FAT3
|
FAT atypical cadherin 3 |
chrX_-_70331298 | 8.70 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr2_-_89513402 | 8.70 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr16_-_28550348 | 8.68 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr12_-_8815215 | 8.64 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr4_-_25865159 | 8.63 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr7_+_73624327 | 8.61 |
ENST00000361082.3
ENST00000275635.7 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family, member 2 |
chr16_-_1661988 | 8.60 |
ENST00000426508.2
|
IFT140
|
intraflagellar transport 140 homolog (Chlamydomonas) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.9 | 286.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
10.4 | 41.5 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
10.0 | 30.0 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
9.1 | 27.4 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
8.8 | 61.6 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
7.6 | 30.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
7.2 | 14.4 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
7.1 | 42.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
6.5 | 19.5 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
6.2 | 18.6 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
6.1 | 18.3 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
5.5 | 65.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
5.4 | 16.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
5.3 | 15.8 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
5.1 | 40.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
5.1 | 25.4 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
4.9 | 14.7 | GO:1990523 | bone regeneration(GO:1990523) |
4.8 | 24.1 | GO:0044858 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
4.5 | 4.5 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
4.5 | 13.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
4.2 | 29.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
4.1 | 61.6 | GO:0015671 | oxygen transport(GO:0015671) |
4.1 | 28.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
4.0 | 12.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
4.0 | 20.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
3.9 | 3.9 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
3.9 | 19.4 | GO:0048539 | bone marrow development(GO:0048539) |
3.9 | 3.9 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
3.9 | 15.4 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) |
3.8 | 18.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
3.8 | 18.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
3.8 | 11.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.8 | 7.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.7 | 14.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
3.7 | 14.7 | GO:0048749 | compound eye development(GO:0048749) |
3.6 | 10.8 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.5 | 17.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
3.5 | 10.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
3.5 | 10.5 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
3.5 | 7.0 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
3.5 | 17.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.4 | 10.3 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
3.4 | 10.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
3.4 | 3.4 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
3.4 | 20.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
3.3 | 16.6 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
3.3 | 19.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
3.2 | 31.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
3.1 | 3.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
3.1 | 3.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
3.1 | 9.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
3.1 | 9.2 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
3.1 | 15.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
3.1 | 67.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.1 | 3.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
3.1 | 39.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
3.0 | 15.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
3.0 | 3.0 | GO:0008355 | olfactory learning(GO:0008355) |
3.0 | 27.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
3.0 | 3.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
3.0 | 29.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
3.0 | 35.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.9 | 5.9 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
2.9 | 2.9 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
2.9 | 2.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
2.9 | 8.6 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
2.9 | 2.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
2.8 | 17.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.8 | 2.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
2.8 | 11.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
2.8 | 8.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
2.8 | 8.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
2.8 | 5.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
2.7 | 13.7 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.7 | 13.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.7 | 10.9 | GO:1902617 | response to fluoride(GO:1902617) |
2.7 | 18.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.7 | 13.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.7 | 2.7 | GO:0044782 | cilium organization(GO:0044782) |
2.7 | 16.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.6 | 13.2 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
2.6 | 23.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
2.6 | 13.1 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
2.6 | 7.8 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
2.6 | 7.8 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
2.6 | 72.1 | GO:0098743 | cell aggregation(GO:0098743) |
2.6 | 15.3 | GO:0051013 | microtubule severing(GO:0051013) |
2.6 | 17.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
2.5 | 10.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
2.5 | 7.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.5 | 20.0 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 7.5 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.5 | 153.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
2.5 | 12.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.4 | 2.4 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
2.4 | 19.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
2.4 | 26.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
2.4 | 9.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
2.3 | 4.7 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
2.3 | 7.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.3 | 20.9 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
2.3 | 7.0 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
2.3 | 6.9 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
2.3 | 4.5 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) |
2.3 | 6.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
2.2 | 11.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
2.2 | 13.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
2.2 | 11.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
2.2 | 2.2 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.2 | 4.3 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.2 | 6.5 | GO:0071529 | cementum mineralization(GO:0071529) |
2.2 | 6.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
2.2 | 4.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
2.1 | 2.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.1 | 6.4 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
2.1 | 8.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
2.1 | 6.4 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.1 | 23.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
2.1 | 10.6 | GO:0097102 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
2.1 | 8.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
2.1 | 4.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
2.1 | 8.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.1 | 2.1 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
2.1 | 12.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.1 | 6.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
2.1 | 22.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
2.1 | 14.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.1 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
2.0 | 6.1 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
2.0 | 6.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
2.0 | 6.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
2.0 | 4.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.0 | 10.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.0 | 8.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
2.0 | 6.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.0 | 19.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.0 | 7.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
2.0 | 4.0 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) T cell extravasation(GO:0072683) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
2.0 | 2.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.0 | 5.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.0 | 5.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
2.0 | 3.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.0 | 2.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
2.0 | 27.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.9 | 21.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.9 | 17.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.9 | 7.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.9 | 3.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.9 | 3.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.9 | 7.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.9 | 7.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
1.9 | 7.8 | GO:0007525 | somatic muscle development(GO:0007525) |
1.9 | 34.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.9 | 7.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
1.9 | 5.7 | GO:0002384 | hepatic immune response(GO:0002384) |
1.9 | 15.2 | GO:0015705 | iodide transport(GO:0015705) |
1.9 | 11.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.9 | 3.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.9 | 222.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.8 | 3.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.8 | 3.7 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
1.8 | 9.1 | GO:0070269 | pyroptosis(GO:0070269) |
1.8 | 7.3 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
1.8 | 1.8 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
1.8 | 1.8 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
1.8 | 144.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.8 | 3.6 | GO:0051665 | membrane raft localization(GO:0051665) |
1.8 | 7.2 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
1.8 | 5.3 | GO:0010193 | response to ozone(GO:0010193) |
1.8 | 1.8 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
1.8 | 5.3 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
1.8 | 3.5 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
1.8 | 5.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.8 | 3.5 | GO:0001757 | somite specification(GO:0001757) |
1.8 | 5.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
1.8 | 26.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.7 | 3.5 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
1.7 | 1.7 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.7 | 1.7 | GO:0031638 | zymogen activation(GO:0031638) |
1.7 | 8.6 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
1.7 | 1.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
1.7 | 12.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.7 | 8.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
1.7 | 5.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
1.7 | 5.1 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
1.7 | 1.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.7 | 6.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
1.7 | 5.0 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
1.7 | 6.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.7 | 3.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
1.7 | 5.0 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.7 | 5.0 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.7 | 8.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
1.7 | 3.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.6 | 6.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
1.6 | 3.3 | GO:0042737 | drug catabolic process(GO:0042737) |
1.6 | 3.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.6 | 4.9 | GO:1903487 | regulation of lactation(GO:1903487) |
1.6 | 4.9 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.6 | 6.6 | GO:0035106 | operant conditioning(GO:0035106) |
1.6 | 3.3 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
1.6 | 4.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.6 | 3.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.6 | 9.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.6 | 6.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.6 | 4.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.6 | 8.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.6 | 9.6 | GO:0015811 | L-cystine transport(GO:0015811) |
1.6 | 6.4 | GO:0036269 | swimming behavior(GO:0036269) |
1.6 | 8.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.6 | 3.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.6 | 3.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
1.6 | 6.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.6 | 11.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.6 | 4.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
1.6 | 4.7 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
1.5 | 3.1 | GO:0003166 | bundle of His development(GO:0003166) |
1.5 | 23.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.5 | 9.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
1.5 | 6.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.5 | 26.0 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.5 | 4.6 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.5 | 19.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.5 | 4.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.5 | 15.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.5 | 68.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.5 | 25.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.5 | 4.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.5 | 1.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.5 | 1.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.5 | 3.0 | GO:0042100 | B cell proliferation(GO:0042100) |
1.5 | 5.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.5 | 1.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
1.5 | 4.4 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.5 | 2.9 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.5 | 8.8 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.5 | 1.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.5 | 8.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.5 | 5.8 | GO:0002215 | defense response to nematode(GO:0002215) |
1.5 | 2.9 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.5 | 2.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.5 | 7.3 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
1.4 | 2.9 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
1.4 | 10.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.4 | 13.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.4 | 4.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.4 | 1.4 | GO:0048535 | lymph node development(GO:0048535) |
1.4 | 5.7 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.4 | 1.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.4 | 5.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
1.4 | 1.4 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
1.4 | 7.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.4 | 2.8 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
1.4 | 4.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
1.4 | 5.6 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
1.4 | 39.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
1.4 | 5.6 | GO:0019086 | late viral transcription(GO:0019086) |
1.4 | 2.8 | GO:0035962 | response to interleukin-13(GO:0035962) |
1.4 | 8.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.4 | 1.4 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.4 | 4.1 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
1.4 | 4.1 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
1.4 | 4.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
1.4 | 4.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.4 | 12.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.4 | 4.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.4 | 2.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.4 | 21.7 | GO:0002347 | response to tumor cell(GO:0002347) |
1.4 | 1.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.4 | 2.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.4 | 4.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.3 | 2.7 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
1.3 | 1.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.3 | 5.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
1.3 | 4.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
1.3 | 9.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
1.3 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.3 | 6.6 | GO:0035624 | receptor transactivation(GO:0035624) |
1.3 | 9.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.3 | 2.6 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
1.3 | 2.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.3 | 1.3 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.3 | 2.6 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
1.3 | 7.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.3 | 1.3 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
1.3 | 11.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 1.3 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
1.3 | 8.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.3 | 20.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
1.3 | 3.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.3 | 3.8 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.3 | 2.5 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
1.3 | 1.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.3 | 20.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.3 | 1.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.3 | 1.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
1.3 | 6.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.2 | 10.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
1.2 | 6.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.2 | 2.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.2 | 7.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.2 | 4.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.2 | 4.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.2 | 3.7 | GO:0031297 | replication fork processing(GO:0031297) |
1.2 | 2.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.2 | 9.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.2 | 17.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.2 | 1.2 | GO:0061511 | centriole elongation(GO:0061511) |
1.2 | 3.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.2 | 1.2 | GO:0051891 | regulation of cardioblast differentiation(GO:0051890) positive regulation of cardioblast differentiation(GO:0051891) |
1.2 | 12.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 1.2 | GO:0071476 | cellular hypotonic response(GO:0071476) |
1.2 | 7.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.2 | 38.5 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
1.2 | 15.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
1.2 | 22.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
1.2 | 3.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.2 | 1.2 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
1.2 | 3.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.2 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.2 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 1.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.2 | 1.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.2 | 2.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.2 | 38.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
1.2 | 1.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.2 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.2 | 12.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.2 | 10.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.2 | 2.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.2 | 17.4 | GO:0045730 | respiratory burst(GO:0045730) |
1.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.2 | 57.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
1.1 | 2.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.1 | 25.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.1 | 3.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.1 | 9.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.1 | 14.8 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
1.1 | 2.3 | GO:0032571 | response to vitamin K(GO:0032571) |
1.1 | 5.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.1 | 4.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
1.1 | 62.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.1 | 5.6 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.1 | 11.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
1.1 | 6.8 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
1.1 | 5.6 | GO:0042116 | macrophage activation(GO:0042116) |
1.1 | 2.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.1 | 2.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 12.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.1 | 3.3 | GO:0048241 | epinephrine transport(GO:0048241) |
1.1 | 2.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
1.1 | 1.1 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
1.1 | 16.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.1 | 6.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
1.1 | 2.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 3.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.1 | 5.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.1 | 3.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.1 | 5.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.1 | 3.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
1.1 | 3.2 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.1 | 8.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.1 | 4.3 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.1 | 2.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.1 | 4.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.1 | 3.2 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
1.1 | 3.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
1.1 | 1.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.1 | 3.2 | GO:0097359 | UDP-glucosylation(GO:0097359) |
1.1 | 2.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.1 | 1.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
1.1 | 18.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.1 | 2.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.1 | 5.3 | GO:0016240 | autophagosome docking(GO:0016240) |
1.1 | 3.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.1 | 6.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.1 | 1.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
1.1 | 20.1 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
1.1 | 25.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
1.1 | 2.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.1 | 3.2 | GO:0070842 | aggresome assembly(GO:0070842) |
1.1 | 5.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 2.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.0 | 4.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
1.0 | 3.1 | GO:0061056 | sclerotome development(GO:0061056) |
1.0 | 1.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.0 | 3.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
1.0 | 1.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.0 | 5.2 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.0 | 4.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.0 | 6.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.0 | 3.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.0 | 2.0 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.0 | 3.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.0 | 2.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.0 | 4.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.0 | 6.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.0 | 3.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.0 | 7.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.0 | 34.1 | GO:0033198 | response to ATP(GO:0033198) |
1.0 | 1.0 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
1.0 | 3.0 | GO:0042756 | drinking behavior(GO:0042756) |
1.0 | 4.0 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
1.0 | 4.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.0 | 2.0 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
1.0 | 3.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.0 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 5.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.0 | 2.0 | GO:0097325 | melanocyte proliferation(GO:0097325) |
1.0 | 5.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.0 | 7.9 | GO:0006477 | protein sulfation(GO:0006477) |
1.0 | 2.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.0 | 1.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.0 | 3.9 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.0 | 2.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 7.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.0 | 132.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.0 | 3.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.0 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.0 | 6.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 1.0 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.0 | 11.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.0 | 18.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.0 | 5.8 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.0 | 5.8 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
1.0 | 1.0 | GO:0072716 | response to actinomycin D(GO:0072716) |
1.0 | 2.9 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.0 | 5.8 | GO:0043201 | response to leucine(GO:0043201) |
1.0 | 2.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.0 | 8.6 | GO:0007320 | insemination(GO:0007320) |
1.0 | 3.8 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
1.0 | 4.8 | GO:0007498 | mesoderm development(GO:0007498) |
1.0 | 3.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 2.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.9 | 12.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.9 | 1.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.9 | 2.8 | GO:0048319 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) mesodermal cell migration(GO:0008078) axial mesoderm morphogenesis(GO:0048319) |
0.9 | 3.8 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.9 | 0.9 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.9 | 2.8 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.9 | 1.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.9 | 7.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.9 | 7.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.9 | 12.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.9 | 2.8 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.9 | 7.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.9 | 0.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.9 | 11.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.9 | 1.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.9 | 1.8 | GO:0009635 | response to herbicide(GO:0009635) |
0.9 | 5.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 2.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.9 | 15.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.9 | 4.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.9 | 0.9 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.9 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.9 | 2.7 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.9 | 0.9 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) negative regulation of dendritic cell cytokine production(GO:0002731) |
0.9 | 7.2 | GO:0015747 | urate transport(GO:0015747) |
0.9 | 4.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.9 | 0.9 | GO:0015942 | formate metabolic process(GO:0015942) |
0.9 | 1.8 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.9 | 3.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.9 | 2.7 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.9 | 9.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.9 | 0.9 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.9 | 0.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.9 | 1.8 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.9 | 7.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.9 | 1.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.9 | 7.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.9 | 1.8 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.9 | 1.8 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.9 | 4.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.9 | 2.6 | GO:0061055 | myotome development(GO:0061055) |
0.9 | 0.9 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.9 | 2.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.9 | 0.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.9 | 1.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.9 | 2.6 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.9 | 4.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.9 | 4.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 0.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.9 | 2.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.9 | 2.6 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.9 | 2.6 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.9 | 3.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.9 | 1.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
0.9 | 6.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.9 | 18.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.9 | 0.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.9 | 3.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.9 | 0.9 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.9 | 1.7 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.8 | 1.7 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.8 | 4.2 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.8 | 2.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 3.4 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.8 | 16.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.8 | 5.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.8 | 1.7 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.8 | 1.7 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.8 | 3.3 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.8 | 0.8 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 11.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.8 | 7.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.8 | 1.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.8 | 5.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.8 | 5.0 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.8 | 3.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 2.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.8 | 3.3 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.8 | 1.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.8 | 0.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.8 | 4.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.8 | 7.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.8 | 4.9 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.8 | 1.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.8 | 3.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.8 | 5.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 2.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.8 | 0.8 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 4.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.8 | 2.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.8 | 6.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.8 | 5.6 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.8 | 0.8 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.8 | 1.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.8 | 2.4 | GO:0044144 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.8 | 4.7 | GO:0045347 | MHC class II biosynthetic process(GO:0045342) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.8 | 2.4 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.8 | 0.8 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.8 | 2.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.8 | 11.8 | GO:0043586 | tongue development(GO:0043586) |
0.8 | 3.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 0.8 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.8 | 15.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.8 | 1.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 3.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.8 | 3.1 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.8 | 5.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.8 | 0.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.8 | 2.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.8 | 6.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.8 | 0.8 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.8 | 1.5 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.8 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 7.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.8 | 2.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 2.3 | GO:0060022 | hard palate development(GO:0060022) |
0.8 | 2.3 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.8 | 3.0 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.8 | 1.5 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.8 | 8.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.8 | 2.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.7 | 4.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.7 | 7.5 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.7 | 0.7 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 4.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 1.5 | GO:0048880 | sensory system development(GO:0048880) |
0.7 | 6.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.7 | 4.5 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.7 | 0.7 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.7 | 5.2 | GO:0045007 | depurination(GO:0045007) |
0.7 | 7.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.7 | 10.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.7 | 3.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.7 | 13.2 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.7 | 4.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 1.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.7 | 7.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.7 | 1.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.7 | 2.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.7 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 5.0 | GO:0007494 | midgut development(GO:0007494) |
0.7 | 0.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.7 | 0.7 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.7 | 2.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.7 | 0.7 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 4.3 | GO:0001554 | luteolysis(GO:0001554) |
0.7 | 2.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.7 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.7 | 14.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.7 | 1.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 2.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.7 | 2.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 0.7 | GO:0038001 | paracrine signaling(GO:0038001) |
0.7 | 2.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.7 | 0.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.7 | 2.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.7 | 6.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 4.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 4.8 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.7 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 15.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.7 | 2.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.7 | 2.8 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 7.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 2.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 2.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.7 | 2.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 3.4 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
0.7 | 0.7 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.7 | 2.7 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.7 | 6.8 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.7 | 6.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 22.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.7 | 2.0 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 6.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.7 | 2.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.7 | 0.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.7 | 2.0 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.7 | 2.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.0 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.7 | 2.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.7 | 2.0 | GO:1903319 | positive regulation of protein maturation(GO:1903319) |
0.7 | 1.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 1.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 3.3 | GO:0015791 | polyol transport(GO:0015791) |
0.7 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 | 2.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.7 | 94.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.7 | 4.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.7 | 20.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.7 | 7.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.7 | 2.0 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.7 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 2.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 1.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 1.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.6 | 0.6 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.6 | 1.9 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.6 | 1.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.6 | 6.4 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.6 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.6 | 1.9 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.6 | 1.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.6 | 15.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.6 | 1.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.6 | 1.9 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.6 | 14.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.6 | 3.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 4.4 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.6 | 1.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 1.9 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.6 | 4.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 1.9 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.6 | 7.4 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.6 | 4.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.6 | 2.5 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) maintenance of DNA repeat elements(GO:0043570) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 1.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.6 | 2.5 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.6 | 1.8 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 0.6 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.6 | 1.8 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.6 | 1.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
0.6 | 4.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.6 | 1.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.6 | 3.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.6 | 1.2 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.6 | 2.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 6.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.6 | 0.6 | GO:0021592 | fourth ventricle development(GO:0021592) third ventricle development(GO:0021678) |
0.6 | 2.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.6 | 1.8 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.6 | 1.8 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.6 | 2.4 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.6 | 9.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.6 | 3.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.6 | 1.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 5.3 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.6 | 23.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.6 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.6 | 1.8 | GO:0001738 | establishment of planar polarity(GO:0001736) morphogenesis of a polarized epithelium(GO:0001738) establishment of tissue polarity(GO:0007164) |
0.6 | 2.4 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.6 | 3.0 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 2.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.6 | 1.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.6 | 2.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 8.8 | GO:0030728 | ovulation(GO:0030728) |
0.6 | 13.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.6 | 8.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.6 | 2.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.6 | 3.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.6 | 1.2 | GO:0007538 | primary sex determination(GO:0007538) |
0.6 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 7.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.6 | 2.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.6 | 11.6 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.6 | 2.9 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.6 | 4.0 | GO:0043584 | nose development(GO:0043584) |
0.6 | 1.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.6 | 1.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 1.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 16.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.6 | 5.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.6 | 7.4 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.6 | 4.0 | GO:0015886 | heme transport(GO:0015886) |
0.6 | 4.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.6 | 4.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.6 | 4.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.6 | 1.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 1.7 | GO:0002118 | aggressive behavior(GO:0002118) |
0.6 | 1.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.6 | 3.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 2.8 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.6 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.6 | 9.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.6 | 1.1 | GO:0061053 | somite development(GO:0061053) |
0.6 | 1.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.6 | 2.8 | GO:0071435 | potassium ion export(GO:0071435) |
0.6 | 4.4 | GO:0007281 | germ cell development(GO:0007281) |
0.6 | 5.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.6 | 5.0 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.6 | 7.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.6 | 5.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.6 | 1.7 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 22.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.5 | 8.2 | GO:0098868 | bone growth(GO:0098868) |
0.5 | 1.1 | GO:0001501 | skeletal system development(GO:0001501) |
0.5 | 4.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 1.1 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.5 | 1.6 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.5 | 1.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 1.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.5 | 4.4 | GO:0048563 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 2.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.5 | 3.8 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.5 | 35.1 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.5 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.5 | 7.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 2.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 1.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.5 | 5.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 18.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.5 | 5.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 4.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 3.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.5 | 5.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 3.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.5 | 2.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 1.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 2.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.5 | 10.6 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.5 | 5.3 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.5 | 2.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
0.5 | 1.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 1.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.5 | 1.6 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.5 | 1.6 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.5 | 0.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 1.0 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.5 | 0.5 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.5 | 3.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 3.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.5 | 15.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.5 | 3.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.5 | 1.5 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.5 | 0.5 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.5 | 2.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.5 | 5.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.5 | 1.0 | GO:2000491 | regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 1.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.5 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 1.5 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 4.5 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.5 | 0.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.5 | 1.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.5 | 1.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.5 | 1.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.5 | 1.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.5 | 0.5 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.5 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.5 | 1.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.5 | 7.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 1.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.5 | 7.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.5 | 2.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.5 | 2.4 | GO:0033504 | floor plate development(GO:0033504) |
0.5 | 1.5 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.5 | 2.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.5 | 2.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 3.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.5 | 2.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.5 | 1.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 1.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.5 | 4.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.5 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.5 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 1.4 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.5 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 3.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 3.3 | GO:0007369 | gastrulation(GO:0007369) |
0.5 | 2.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 5.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 2.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 7.0 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.9 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.5 | 0.9 | GO:0070091 | glucagon secretion(GO:0070091) |
0.5 | 0.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 1.9 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.5 | 0.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.5 | 63.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.5 | 3.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 4.6 | GO:0050817 | coagulation(GO:0050817) |
0.5 | 1.4 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 4.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.5 | 4.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.5 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 0.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 0.4 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.4 | 0.9 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 0.9 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.4 | 3.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.4 | 1.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.4 | 1.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 2.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.9 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.4 | 0.9 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.4 | 0.9 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.4 | 2.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.4 | 2.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 1.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.4 | 3.9 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.4 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 1.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.4 | 1.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 13.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.4 | 2.2 | GO:0032885 | regulation of polysaccharide biosynthetic process(GO:0032885) |
0.4 | 1.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.4 | 3.0 | GO:0044241 | lipid digestion(GO:0044241) |
0.4 | 2.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.4 | 22.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.4 | 3.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 2.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 0.8 | GO:0036337 | Fas signaling pathway(GO:0036337) regulation of Fas signaling pathway(GO:1902044) |
0.4 | 14.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 3.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 13.6 | GO:0060021 | palate development(GO:0060021) |
0.4 | 2.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.4 | 2.0 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.4 | 4.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.4 | 1.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 0.8 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.4 | 2.0 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
0.4 | 1.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 2.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 | 3.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.4 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 4.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 4.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.4 | 3.2 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.4 | 1.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 2.4 | GO:0007588 | excretion(GO:0007588) |
0.4 | 2.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.4 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 8.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 1.2 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.4 | 0.4 | GO:1903044 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) protein localization to membrane raft(GO:1903044) |
0.4 | 9.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.4 | 1.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.4 | 0.8 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.4 | 0.4 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.4 | 3.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.4 | 2.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 1.5 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.4 | 1.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.4 | 1.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 5.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.4 | 1.5 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
0.4 | 1.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.4 | 0.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.4 | 1.5 | GO:0043387 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.4 | 2.9 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 2.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 3.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.4 | 0.7 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.4 | 0.4 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.4 | 1.1 | GO:0046530 | photoreceptor cell differentiation(GO:0046530) |
0.4 | 1.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 5.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.4 | 13.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 1.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.4 | 3.2 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 1.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 1.7 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.3 | 3.8 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 1.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.3 | 1.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.3 | 1.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 2.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 7.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 1.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 0.7 | GO:0009111 | vitamin catabolic process(GO:0009111) |
0.3 | 1.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 0.3 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.3 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.3 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 1.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 0.7 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.3 | 1.0 | GO:0010452 | regulation of histone H3-K36 methylation(GO:0000414) histone H3-K36 methylation(GO:0010452) |
0.3 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 5.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 3.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 0.7 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 2.3 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.3 | 1.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 2.0 | GO:0007292 | female gamete generation(GO:0007292) |
0.3 | 3.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 1.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.3 | 3.9 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.3 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.9 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 1.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 0.6 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.3 | 0.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.3 | 0.3 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.3 | 2.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 19.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.3 | 5.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 23.3 | GO:0070268 | cornification(GO:0070268) |
0.3 | 5.2 | GO:0060384 | innervation(GO:0060384) |
0.3 | 1.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 3.0 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.3 | 0.6 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.3 | 0.9 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 0.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
0.3 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.3 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.3 | 0.6 | GO:0007619 | courtship behavior(GO:0007619) |
0.3 | 0.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.3 | 0.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 12.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 1.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 1.5 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 1.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 2.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.3 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 33.8 | GO:0007601 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.3 | 2.5 | GO:0051181 | cofactor transport(GO:0051181) |
0.3 | 2.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.3 | 3.9 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 0.6 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 1.7 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 1.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 1.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.3 | 1.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.3 | 3.9 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.3 | 1.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 0.5 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.3 | 0.8 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.3 | 0.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 1.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.3 | 3.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 0.3 | GO:2000232 | regulation of ribosome biogenesis(GO:0090069) regulation of rRNA processing(GO:2000232) |
0.3 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.3 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.5 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.3 | 2.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.3 | 1.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 0.3 | GO:0061073 | anterior commissure morphogenesis(GO:0021960) ciliary body morphogenesis(GO:0061073) |
0.3 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 1.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 2.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.3 | 2.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 3.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 0.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.7 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.2 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 4.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 1.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 1.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 1.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 1.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 2.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.2 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.2 | 0.9 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.2 | 0.7 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.2 | 0.5 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 1.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 1.8 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 0.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 1.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.5 | GO:0030301 | cholesterol transport(GO:0030301) |
0.2 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 2.5 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.2 | 0.9 | GO:1905225 | cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.2 | 1.4 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 3.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 1.4 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.2 | 1.1 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.2 | 1.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.7 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.2 | 1.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.2 | 0.9 | GO:0055001 | muscle cell development(GO:0055001) |
0.2 | 0.9 | GO:0019046 | release from viral latency(GO:0019046) |
0.2 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.2 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 1.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.5 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.2 | 0.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 2.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 6.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.2 | 0.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 2.7 | GO:0006312 | mitotic recombination(GO:0006312) |
0.2 | 1.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 2.5 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.2 | 1.0 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 1.7 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.2 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.4 | GO:0046219 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.2 | 2.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 1.6 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.4 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 1.0 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 4.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 1.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 3.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.4 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 2.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 4.4 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.6 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 0.6 | GO:0097021 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 2.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 1.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 0.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 2.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 1.6 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.7 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.7 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.2 | GO:0048644 | muscle organ morphogenesis(GO:0048644) cardiac muscle tissue morphogenesis(GO:0055008) |
0.2 | 3.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.9 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.2 | 0.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 1.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 3.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.3 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.2 | 0.8 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.2 | 0.8 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) brush border assembly(GO:1904970) |
0.2 | 0.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 2.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.2 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 4.9 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.9 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.2 | 0.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.3 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 0.5 | GO:0003014 | renal system process(GO:0003014) |
0.2 | 0.5 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.7 | GO:0075733 | intracellular transport of virus(GO:0075733) |
0.1 | 0.6 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.7 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.1 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.1 | 0.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.3 | GO:1904036 | negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.7 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 1.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 1.3 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 2.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 1.0 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.8 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 3.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.3 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.1 | 10.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 9.1 | GO:0050776 | regulation of immune response(GO:0050776) |
0.1 | 1.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) |
0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.1 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 1.6 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 1.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.5 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.1 | 0.4 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.1 | 0.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.7 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.5 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.8 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 1.2 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 0.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 2.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 5.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.1 | 2.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.3 | GO:0071871 | response to epinephrine(GO:0071871) |
0.1 | 3.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.7 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.1 | 0.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.3 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 1.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.3 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.1 | 0.3 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 1.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.3 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.1 | 0.2 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.1 | 0.3 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 3.4 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 1.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0021778 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.7 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.1 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
0.1 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 4.0 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.1 | 0.2 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0032941 | body fluid secretion(GO:0007589) secretion by tissue(GO:0032941) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.2 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.2 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.2 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 1.2 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 1.8 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 0.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.1 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.0 | 0.0 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 1.4 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.1 | 323.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
8.2 | 171.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
6.3 | 18.9 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
5.0 | 30.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
4.7 | 14.0 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
4.6 | 32.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
4.5 | 63.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.3 | 17.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
4.2 | 29.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
4.1 | 12.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
3.9 | 35.3 | GO:0005579 | membrane attack complex(GO:0005579) |
3.7 | 22.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.5 | 17.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
3.3 | 6.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
3.3 | 16.5 | GO:0071546 | pi-body(GO:0071546) |
3.2 | 3.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
3.1 | 24.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
3.0 | 33.5 | GO:0042611 | MHC protein complex(GO:0042611) |
3.0 | 8.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.9 | 136.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
2.9 | 2.9 | GO:0000346 | transcription export complex(GO:0000346) |
2.9 | 28.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
2.8 | 5.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
2.6 | 7.9 | GO:0044609 | DBIRD complex(GO:0044609) |
2.6 | 38.6 | GO:0030478 | actin cap(GO:0030478) |
2.6 | 48.8 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 20.2 | GO:0035976 | AP1 complex(GO:0035976) |
2.4 | 52.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
2.4 | 11.9 | GO:0000801 | central element(GO:0000801) |
2.3 | 2.3 | GO:0042599 | lamellar body(GO:0042599) |
2.3 | 7.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
2.3 | 15.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
2.2 | 6.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.1 | 12.9 | GO:0032010 | phagolysosome(GO:0032010) |
2.1 | 6.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.1 | 10.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
2.1 | 6.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
2.0 | 49.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.9 | 7.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
1.9 | 1.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
1.9 | 20.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.8 | 9.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.8 | 3.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.8 | 10.7 | GO:0002177 | manchette(GO:0002177) |
1.8 | 10.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.7 | 20.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.7 | 3.4 | GO:0097679 | other organism cytoplasm(GO:0097679) |
1.7 | 3.4 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
1.7 | 21.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.6 | 50.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.6 | 3.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
1.6 | 9.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.6 | 1.6 | GO:0001740 | Barr body(GO:0001740) |
1.6 | 14.1 | GO:0016013 | syntrophin complex(GO:0016013) |
1.6 | 6.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.6 | 6.2 | GO:1990745 | EARP complex(GO:1990745) |
1.5 | 24.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.5 | 1.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
1.5 | 10.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.5 | 16.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.5 | 5.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 77.3 | GO:0001533 | cornified envelope(GO:0001533) |
1.5 | 16.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.4 | 1.4 | GO:0000938 | GARP complex(GO:0000938) |
1.4 | 4.3 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
1.4 | 48.4 | GO:0042629 | mast cell granule(GO:0042629) |
1.4 | 5.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.3 | 6.7 | GO:0036398 | TCR signalosome(GO:0036398) |
1.3 | 2.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.3 | 10.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.3 | 9.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.3 | 3.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.2 | 3.7 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
1.2 | 8.5 | GO:0032437 | cuticular plate(GO:0032437) |
1.2 | 3.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
1.2 | 3.6 | GO:0098536 | deuterosome(GO:0098536) |
1.2 | 4.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.2 | 16.8 | GO:0036038 | MKS complex(GO:0036038) |
1.2 | 7.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.2 | 2.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.2 | 5.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.2 | 7.1 | GO:1990037 | Lewy body core(GO:1990037) |
1.2 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.1 | 23.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 7.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.1 | 4.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.1 | 109.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
1.1 | 5.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 9.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 8.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.0 | 22.5 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 9.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 4.1 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
1.0 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
1.0 | 72.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
1.0 | 232.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.0 | 10.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.0 | 1.9 | GO:0032009 | early phagosome(GO:0032009) |
0.9 | 8.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 103.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.9 | 10.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.9 | 5.5 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.9 | 7.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.9 | 6.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.9 | 3.5 | GO:0005712 | chiasma(GO:0005712) |
0.9 | 3.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.9 | 2.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 5.9 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 2.5 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.8 | 5.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.8 | 3.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 2.4 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.8 | 59.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 103.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 5.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 0.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.8 | 28.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.8 | 6.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.8 | 2.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 2.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 2.2 | GO:0031251 | PAN complex(GO:0031251) |
0.7 | 2.8 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.7 | 5.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.7 | 4.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 6.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 7.6 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.7 | 2.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 6.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 9.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.7 | 2.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.7 | 2.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.7 | 55.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 3.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.7 | 2.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 1.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 0.7 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.7 | 4.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.7 | 3.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.7 | 77.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.7 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.6 | 2.6 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 1.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.6 | 2.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 15.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.6 | 17.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 7.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.6 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 22.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.6 | 36.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 3.0 | GO:0089701 | U2AF(GO:0089701) |
0.6 | 719.5 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 1.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.6 | 3.5 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 6.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.6 | 1.7 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 1.7 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 34.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.5 | 5.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.5 | 1.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.5 | 2.6 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 6.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 2.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 34.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.5 | 2.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.5 | 7.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 5.9 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.5 | 1.5 | GO:0031213 | RSF complex(GO:0031213) |
0.5 | 20.0 | GO:0002102 | podosome(GO:0002102) |
0.5 | 1.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 14.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 8.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 4.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 36.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.5 | 3.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.4 | 2.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.4 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 46.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.4 | 1.7 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.4 | 2.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
0.4 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 18.7 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 4.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 14.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 2.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 0.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.4 | 2.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 5.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 7.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 1.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 5.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 2.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 1.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 12.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 3.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 3.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.3 | 1.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 7.0 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 11.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 2.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.3 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 13.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 2.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 1.0 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 0.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 2.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 2.1 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 14.8 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 27.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 288.2 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 2.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.2 | 1.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.4 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.1 | 1.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 15.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 1.4 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 7.0 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.4 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.1 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 4.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 2.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 27.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 6.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 1.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 1.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 1.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.1 | GO:0005901 | caveola(GO:0005901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.1 | 52.5 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
9.8 | 58.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
7.4 | 22.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
6.7 | 94.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
6.6 | 19.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
6.5 | 19.5 | GO:0035501 | MH1 domain binding(GO:0035501) |
6.3 | 18.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
6.0 | 17.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
5.6 | 28.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
5.3 | 15.8 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
5.2 | 36.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
5.1 | 30.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
4.4 | 17.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
4.4 | 35.0 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
4.3 | 13.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
4.2 | 310.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
4.1 | 32.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
3.7 | 41.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
3.7 | 11.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
3.6 | 14.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
3.6 | 105.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
3.6 | 18.1 | GO:0019863 | IgE binding(GO:0019863) |
3.6 | 25.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.5 | 17.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
3.4 | 34.5 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
3.4 | 13.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.4 | 20.5 | GO:1990254 | keratin filament binding(GO:1990254) |
3.3 | 13.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
3.2 | 19.4 | GO:0003796 | lysozyme activity(GO:0003796) |
3.2 | 3.2 | GO:0001851 | complement component C3b binding(GO:0001851) |
3.1 | 3.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
3.1 | 9.4 | GO:0034584 | piRNA binding(GO:0034584) |
3.0 | 38.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
3.0 | 8.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.9 | 2.9 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
2.9 | 29.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.9 | 2.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
2.9 | 8.6 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
2.9 | 2.9 | GO:0043199 | sulfate binding(GO:0043199) |
2.7 | 8.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
2.7 | 149.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
2.7 | 2.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
2.6 | 15.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.5 | 22.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
2.5 | 7.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
2.5 | 7.5 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
2.5 | 7.4 | GO:0008430 | selenium binding(GO:0008430) |
2.5 | 7.4 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
2.5 | 7.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
2.5 | 7.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
2.5 | 12.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.4 | 7.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
2.4 | 24.4 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
2.4 | 7.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
2.4 | 7.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.4 | 24.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.4 | 7.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.3 | 16.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.3 | 30.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.3 | 6.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.3 | 13.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.2 | 11.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.2 | 26.3 | GO:0045159 | myosin II binding(GO:0045159) |
2.2 | 4.4 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
2.2 | 39.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.2 | 10.9 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
2.2 | 6.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
2.2 | 32.6 | GO:0019864 | IgG binding(GO:0019864) |
2.2 | 10.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
2.2 | 6.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
2.2 | 23.8 | GO:0004875 | complement receptor activity(GO:0004875) |
2.1 | 10.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.1 | 4.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
2.1 | 6.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.1 | 6.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
2.0 | 6.1 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
2.0 | 8.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
2.0 | 14.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.0 | 28.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
2.0 | 6.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.0 | 8.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
2.0 | 10.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.0 | 18.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.0 | 12.0 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.0 | 18.0 | GO:0043426 | MRF binding(GO:0043426) |
2.0 | 69.7 | GO:0008009 | chemokine activity(GO:0008009) |
2.0 | 8.0 | GO:0017022 | myosin binding(GO:0017022) |
2.0 | 2.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.0 | 49.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.0 | 13.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
2.0 | 2.0 | GO:0070052 | collagen V binding(GO:0070052) |
2.0 | 11.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.9 | 15.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.9 | 9.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
1.9 | 5.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
1.9 | 5.7 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.9 | 5.7 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
1.9 | 13.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.9 | 7.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.8 | 5.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
1.8 | 240.4 | GO:0003823 | antigen binding(GO:0003823) |
1.8 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.8 | 9.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.8 | 5.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
1.8 | 3.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.8 | 17.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.7 | 1.7 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.7 | 7.0 | GO:0050692 | DBD domain binding(GO:0050692) |
1.7 | 12.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.7 | 5.2 | GO:0032090 | Pyrin domain binding(GO:0032090) |
1.7 | 13.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.7 | 12.0 | GO:0008142 | oxysterol binding(GO:0008142) |
1.7 | 8.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.7 | 22.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.7 | 15.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
1.7 | 5.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
1.7 | 6.8 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
1.7 | 11.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.7 | 5.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.7 | 5.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.7 | 34.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.7 | 5.0 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.7 | 6.6 | GO:0016160 | amylase activity(GO:0016160) |
1.7 | 6.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.6 | 8.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.6 | 6.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.6 | 4.9 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
1.6 | 4.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
1.6 | 6.4 | GO:0032810 | sterol response element binding(GO:0032810) |
1.6 | 9.6 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.6 | 8.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.6 | 4.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.6 | 12.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.6 | 14.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.6 | 7.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.6 | 17.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.6 | 4.7 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.5 | 16.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.5 | 1.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.5 | 116.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
1.5 | 20.8 | GO:0050700 | CARD domain binding(GO:0050700) |
1.5 | 7.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.5 | 7.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.5 | 7.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
1.5 | 17.6 | GO:0001968 | fibronectin binding(GO:0001968) |
1.5 | 4.4 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.5 | 5.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.5 | 5.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.4 | 155.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.4 | 10.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.4 | 2.9 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
1.4 | 7.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.4 | 5.7 | GO:0030305 | heparanase activity(GO:0030305) |
1.4 | 15.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.4 | 5.6 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
1.4 | 5.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
1.4 | 5.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.4 | 4.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.4 | 4.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.4 | 5.4 | GO:0008431 | vitamin E binding(GO:0008431) |
1.3 | 4.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.3 | 4.0 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
1.3 | 9.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.3 | 8.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.3 | 4.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.3 | 1.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
1.3 | 5.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
1.3 | 3.9 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
1.3 | 3.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.3 | 3.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.3 | 1.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.3 | 2.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.2 | 10.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.2 | 3.7 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
1.2 | 21.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.2 | 3.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.2 | 4.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.2 | 4.9 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.2 | 3.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.2 | 4.9 | GO:0047708 | biotinidase activity(GO:0047708) |
1.2 | 1.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.2 | 3.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.2 | 3.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
1.2 | 6.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.2 | 4.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.2 | 6.0 | GO:0034191 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
1.2 | 4.8 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
1.2 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.2 | 3.6 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.2 | 3.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.2 | 16.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.2 | 2.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
1.2 | 1.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.2 | 57.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
1.2 | 6.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.2 | 6.9 | GO:0045569 | TRAIL binding(GO:0045569) |
1.1 | 9.2 | GO:0005497 | androgen binding(GO:0005497) |
1.1 | 4.6 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.1 | 9.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.1 | 10.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.1 | 4.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
1.1 | 4.6 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.1 | 1.1 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
1.1 | 8.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.1 | 22.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.1 | 3.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.1 | 3.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
1.1 | 19.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 5.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
1.1 | 4.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.1 | 3.3 | GO:0004663 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
1.1 | 3.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.1 | 3.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.1 | 3.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.1 | 4.3 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.1 | 6.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.1 | 8.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 3.2 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
1.1 | 5.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.1 | 4.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.1 | 3.2 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
1.1 | 6.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.1 | 22.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
1.1 | 13.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.1 | 4.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
1.1 | 17.9 | GO:0038191 | neuropilin binding(GO:0038191) |
1.1 | 2.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.1 | 17.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.0 | 4.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.0 | 6.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.0 | 10.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.0 | 4.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
1.0 | 3.1 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
1.0 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 3.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 7.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 2.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 4.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.0 | 5.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.0 | 1.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
1.0 | 3.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
1.0 | 3.0 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
1.0 | 5.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.0 | 18.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.0 | 1.0 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.0 | 8.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.0 | 5.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
1.0 | 6.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.0 | 3.9 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.0 | 4.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
1.0 | 10.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.0 | 6.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.0 | 36.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.0 | 6.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 18.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.0 | 6.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.0 | 2.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
1.0 | 2.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 15.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.9 | 5.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 8.5 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.9 | 4.7 | GO:0070697 | activin receptor binding(GO:0070697) |
0.9 | 4.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.9 | 6.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 1.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.9 | 4.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.9 | 4.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.9 | 14.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.9 | 19.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.9 | 4.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.9 | 12.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.9 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
0.9 | 3.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 15.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.9 | 11.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.9 | 1.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.9 | 3.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.9 | 0.9 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.9 | 2.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.9 | 4.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.9 | 4.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 7.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 4.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 4.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 6.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.8 | 2.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.8 | 1.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.8 | 14.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 2.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.8 | 3.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.8 | 8.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 4.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.8 | 13.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 7.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 4.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 5.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.8 | 6.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 2.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.8 | 4.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 1.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.8 | 3.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.8 | 6.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.8 | 3.1 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.8 | 7.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.8 | 3.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.8 | 3.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.8 | 5.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.8 | 3.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.8 | 1.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.8 | 5.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.8 | 12.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 2.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.8 | 3.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.7 | 3.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.7 | 4.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 33.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 5.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.7 | 2.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 3.0 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.7 | 1.5 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.7 | 0.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.7 | 40.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.7 | 5.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.7 | 2.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.7 | 7.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.7 | 0.7 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.7 | 4.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.7 | 7.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 6.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 2.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.7 | 2.8 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.7 | 7.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.7 | 2.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 9.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.7 | 6.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 13.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.7 | 0.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 2.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.7 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 3.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.7 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 8.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.7 | 4.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.7 | 2.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.7 | 17.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.7 | 74.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.7 | 4.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.7 | 1.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 2.6 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.7 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.6 | 7.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.6 | 0.6 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.6 | 1.9 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.6 | 3.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.6 | 14.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 1.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.6 | 1.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.6 | 5.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.6 | 25.7 | GO:0032934 | cholesterol binding(GO:0015485) sterol binding(GO:0032934) |
0.6 | 5.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.6 | 1.9 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.6 | 17.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.6 | 3.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 3.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.6 | 2.5 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.6 | 2.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.6 | 1.8 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.6 | 1.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.6 | 42.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.6 | 3.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 7.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 3.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.6 | 2.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 6.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 20.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 4.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 3.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.6 | 4.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.6 | 3.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.6 | 5.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.6 | 1.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.6 | 2.9 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.6 | 16.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.6 | 9.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.6 | 15.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 2.9 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.6 | 11.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.6 | 5.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.6 | 1.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 1.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 2.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.6 | 2.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 24.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.6 | 18.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 2.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 2.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 5.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 6.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 12.4 | GO:0005254 | chloride channel activity(GO:0005254) |
0.5 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.5 | 10.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 3.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 2.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 1.0 | GO:0051379 | alpha2-adrenergic receptor activity(GO:0004938) epinephrine binding(GO:0051379) |
0.5 | 1.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.5 | 4.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 2.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 0.5 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.5 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 1.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 1.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 2.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 72.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 3.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 1.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.5 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 2.0 | GO:0004803 | transposase activity(GO:0004803) |
0.5 | 5.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 48.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 9.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.5 | 10.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 4.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.5 | 0.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.5 | 0.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 2.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.5 | 1.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.5 | 0.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 2.8 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.5 | 5.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 4.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.5 | 2.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 6.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 3.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 4.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 2.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.5 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 5.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) bioactive lipid receptor activity(GO:0045125) |
0.5 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 2.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 5.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.4 | 77.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 2.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 1.3 | GO:0032093 | SAM domain binding(GO:0032093) |
0.4 | 10.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 2.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 1.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 0.9 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.4 | 42.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 0.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.4 | 2.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.4 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.3 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.4 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 4.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 4.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 4.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 4.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.4 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 2.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 5.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 2.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 1.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.4 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 1.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.4 | 8.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.4 | 18.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 3.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.4 | 3.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 2.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.4 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 2.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 0.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.4 | 2.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 7.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 4.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 6.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.4 | 4.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 4.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 5.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 3.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.4 | 1.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 7.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.4 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 2.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 1.8 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 1.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 1.0 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.3 | 13.1 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 1.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 2.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 371.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.3 | 1.7 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.3 | 0.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 11.2 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.0 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 17.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 0.7 | GO:0097617 | annealing activity(GO:0097617) |
0.3 | 11.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 1.0 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.3 | 3.6 | GO:0070700 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
0.3 | 2.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.3 | 2.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 2.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 1.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.3 | 1.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 2.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.3 | 6.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 4.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.3 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 0.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 0.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 30.3 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 1.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 1.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.3 | 2.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 2.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 5.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.8 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 2.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 2.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 3.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.9 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.3 | 2.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 4.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 10.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.5 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.3 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 3.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.3 | 1.4 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 0.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.3 | 2.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.7 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.3 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.3 | 1.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 3.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 6.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 6.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 2.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 0.8 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.3 | 1.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 1.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.3 | 14.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 1.0 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.3 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.5 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 4.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 4.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 2.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 1.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 3.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.9 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.2 | 1.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 2.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 4.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 2.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.9 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 1.3 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.4 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.4 | GO:0031545 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 2.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.2 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 2.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.7 | GO:0015278 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 3.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 5.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.5 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.2 | 0.3 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.2 | 0.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 5.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 1.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 4.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 3.0 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.2 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 4.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 45.9 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
0.2 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.6 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.1 | 0.4 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.1 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 3.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 26.4 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.9 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.1 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 2.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 6.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 3.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.3 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 4.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 5.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.1 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 5.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.5 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.7 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.6 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 2.0 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.0 | 0.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 349.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
2.7 | 5.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.7 | 5.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
2.4 | 4.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
2.3 | 121.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.0 | 58.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.8 | 3.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.7 | 24.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.6 | 1.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.5 | 50.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 70.3 | NABA COLLAGENS | Genes encoding collagen proteins |
1.4 | 4.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.3 | 224.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.3 | 124.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.2 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.2 | 57.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.2 | 5.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.1 | 9.2 | PID FOXO PATHWAY | FoxO family signaling |
1.1 | 5.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.1 | 10.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.1 | 4.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 12.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 265.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.0 | 15.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.0 | 89.1 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 18.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.0 | 57.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 49.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 26.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 83.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.9 | 6.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.9 | 29.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.9 | 8.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 24.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.8 | 9.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 6.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 3.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.7 | 11.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.7 | 12.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 12.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.7 | 31.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 146.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.7 | 14.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 6.4 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 45.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.6 | 22.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 19.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 181.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.6 | 11.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 19.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 6.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 1.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 12.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 16.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 8.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 9.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 7.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 17.9 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 2.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 6.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 4.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 11.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 7.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 4.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 4.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 2.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 4.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 6.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 5.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 1.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 4.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 1.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 14.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 3.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 4.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 6.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 2.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 4.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.1 | 300.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
6.7 | 6.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
5.9 | 136.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
5.8 | 23.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.4 | 34.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.1 | 15.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
3.0 | 62.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
2.4 | 43.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.4 | 23.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
2.3 | 31.9 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
2.1 | 4.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
2.1 | 162.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.9 | 111.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.9 | 13.2 | REACTOME DEFENSINS | Genes involved in Defensins |
1.7 | 25.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.7 | 18.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.6 | 25.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.6 | 3.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.5 | 11.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.4 | 35.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.4 | 21.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.4 | 19.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.3 | 20.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.3 | 45.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.3 | 32.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 14.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.3 | 15.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.3 | 17.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.2 | 34.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.2 | 22.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.2 | 14.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.2 | 24.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.1 | 17.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.1 | 2.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.1 | 1.1 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
1.1 | 60.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.1 | 12.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
1.1 | 22.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.0 | 35.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
1.0 | 78.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.0 | 51.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.0 | 3.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.0 | 59.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.0 | 18.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.0 | 18.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 9.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.9 | 22.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.9 | 0.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.9 | 0.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.9 | 32.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.9 | 7.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.9 | 4.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.9 | 17.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 8.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.9 | 27.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.9 | 36.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.8 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 27.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 15.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 286.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.8 | 106.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 129.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.8 | 64.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.8 | 20.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 25.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 1.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 1.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.8 | 2.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 24.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 32.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 7.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 9.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.7 | 75.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 69.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 9.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.6 | 21.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.6 | 23.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.6 | 4.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 3.7 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.6 | 3.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.6 | 11.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.6 | 11.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 18.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 2.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.6 | 28.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 6.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 6.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.6 | 21.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 9.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.5 | 10.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.5 | 7.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 1.6 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.5 | 2.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 6.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 15.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 10.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.5 | 5.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.5 | 2.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 20.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 42.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 6.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 5.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 4.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 8.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 13.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 2.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 4.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.4 | 0.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.4 | 5.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 7.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 0.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 8.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 1.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 8.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.3 | 5.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 2.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.3 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 4.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.3 | 12.8 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 4.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 5.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 5.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 5.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 1.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 4.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 7.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 8.8 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 5.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 2.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 31.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 3.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 3.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.2 | 1.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 3.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 2.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 0.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 3.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 3.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 7.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 2.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 8.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 1.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |